Family Medicine in New Castle, DE
13 verified family medicine doctors in New Castle.
Family medicine physicians provide comprehensive primary care for patients of all ages, from newborns to seniors — managing everyday illness, chronic conditions, and preventive care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Delaware Board of Medical Licensure & Discipline
Dr. Sridevi Donepudi, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mark Trochimowicz, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Driban, MD
Family Medicine
CMS Open Payments· $17.48 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$17.48
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 68th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to David Driban do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vijaya Yezdani, MD
Family Medicine
CMS Open Payments· $451.89 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$451.89
Total received
23
Transactions
10
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Vijaya Yezdani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Khaja Yezdani, MD
Family Medicine
CMS Open Payments· $1,134 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,134
Total received
61
Transactions
16
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Khaja Yezdani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Maria Mancuso, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Edmund Scott, DO
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Gregory Papa, DO
Family Medicine
CMS Open Payments· $4,248 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$4,248
Total received
251
Transactions
23
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Gregory Papa do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joanne Viola, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Joelle Mengang, MD
Family Medicine
CMS Open Payments· $21.36 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$21.36
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 70th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Joelle Mengang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jeena Zachariah, MD
Family Medicine
CMS Open Payments· $114.71 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$114.71
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 136,402 family medicine doctors we've analyzed, about 35% received any industry payment (median $151 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US family medicine doctors.
Payments to Jeena Zachariah do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rebecca Dewees, MD
Family Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.